Differential expression of CD44v6 in adenocarcinoma of the pancreas: an immunohistochemical study
Authors:
- 1 November 1996
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 429-429 (4-5) , 191-195
Abstract
Alternative splicing gives rise to numerous CD44 isoforms, some of which seem to have a role in tumour metastasis. Specifically, a variant form of CD44 with sequences encoded by exon v6 (CD44v6) confers metastatic potential when transfected into a nonmetastasizing cell line of rat pancreatic adenocarcinoma. This study has investigated standard CD44 (CD44s) and CD44v6 expression immunohistochemically in 6 samples of normal pancreatic tissue, 4 of tissue affected by chronic pancreatitis, and 24 of tissue from metastasizing and nonmetastasizing pancreatic adenocarcinomas. In addition, 18 samples from lymph node or visceral metastases were included in the study. CD44s was expressed in nonneoplastic tissue and in tissue from pancreatic adenocarcinomas. In contrast, CD44v6 was not detected in any of the normal tissue or chronic pancreatitis specimens, whereas 54% of pancreatic adenocarcinomas and 55% of metastases expressed this variant exon. Although it is not clear whether CD44 isoforms containing exon v6 play a part in malignant progression in the human exocrine pancreas, it seems plausible that the expression of multiple isoforms containing this and other variant exon confers a selective advantage on pancreatic adenocarcinoma.Keywords
This publication has 19 references indexed in Scilit:
- CD44v6 expression in non‐Hodgkin's lymphoma: An association with low histological grade and poor prognosisThe Journal of Pathology, 1995
- The Significance of CD44 in Human Pancreatic CancerPancreas, 1994
- The Significance of CD44 in Human Pancreatic CancerPancreas, 1994
- Prevention of tumor metastasis formation by anti-variant CD44.Journal of Experimental Medicine, 1993
- CD44 and Its Interaction with Extracellular Matrix1993
- Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.Proceedings of the National Academy of Sciences, 1992
- A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion.Journal of Cell Biology, 1992
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in manEuropean Journal of Immunology, 1986
- Lymph node involvement in carcinoma of the head of the pancreas areaCancer, 1978